Abujarour Ramzey, Dinella Jason, Pribadi Mochtar, Fong Lauren K, Denholtz Matthew, Gutierrez Alma, Haynes Matt, Mahmood Enaaya, Lee Tom T, Ding Sheng, Valamehr Bahram
Fate Therapeutics, San Diego, CA 92121, USA.
School of Pharmaceutical Sciences, Tsinghua University, Beijing, China.
Future Sci OA. 2024 May 15;10(1):FSO964. doi: 10.2144/fsoa-2023-0257. eCollection 2024.
We explored the generation of human induced pluripotent stem cells (iPSCs) solely through the transcriptional activation of endogenous genes by CRISPR activation (CRISPRa). Minimal number of human-specific guide RNAs targeting a limited set of loci were used with a unique cocktail of small molecules (CRISPRa-SM). iPSC clones were efficiently generated by CRISPRa-SM, expressed general and naive iPSC markers and clustered with high-quality iPSCs generated using conventional reprogramming methods. iPSCs showed genomic stability and robust pluripotent potential as assessed by and . CRISPRa-SM-generated human iPSCs by direct and multiplexed loci activation facilitating a unique and potentially safer cellular reprogramming process to aid potential applications in cellular therapy and regenerative medicine.
我们探索了仅通过CRISPR激活(CRISPRa)内源性基因的转录激活来生成人类诱导多能干细胞(iPSC)。使用针对有限位点集的最少数量的人类特异性引导RNA与独特的小分子混合物(CRISPRa-SM)。CRISPRa-SM有效地产生了iPSC克隆,这些克隆表达了一般和原始的iPSC标志物,并与使用传统重编程方法产生的高质量iPSC聚集在一起。通过[具体评估方式1]和[具体评估方式2]评估,iPSC显示出基因组稳定性和强大的多能潜力。通过直接和多重位点激活产生的CRISPRa-SM人类iPSC促进了独特且可能更安全的细胞重编程过程,以辅助细胞治疗和再生医学中的潜在应用。